<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>Saisei Ventures Appoints James Feliciano as Venture Partner — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Saisei Ventures Appoints James Feliciano as Venture Partner</h2>
    <div class="badge">2025-09-15T13:00:00+00:00</div>
    <ul>
      <li>With more than 20 years of experience as a pharmaceutical executive in Japan, Mr.</li>
<li>CAMBRIDGE, Mass., September 15, 2025--(BUSINESS WIRE)--Saisei Ventures, a leading investment firm focused on advancing Japanese biotechnology and therapeutic innovations, today announced that Mr.</li>
<li>At Saisei, Mr.</li>
<li>Feliciano holds a B.A.</li>
<li>Prior to 3C Advisors, Mr.</li>
<li>&quot;We’re thrilled to welcome Mr.</li>
<li>Earlier in his career at Pfizer, Mr.</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=Saisei Ventures Appoints James Feliciano as Venture Partner\n• With more than 20 years of experience as a pharmaceutical executive in Japan, Mr.\n• CAMBRIDGE, Mass., September 15, 2025--(BUSINESS WIRE)--Saisei Ventures, a leading investment firm focused on advancing Japanese biotechnology and therapeutic innovations, today announced that Mr.\n• At Saisei, Mr.\n• Feliciano holds a B.A.\n• Prior to 3C Advisors, Mr.\n• &quot;We’re thrilled to welcome Mr.\n• Earlier in his career at Pfizer, Mr." target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/saisei-ventures-appoints-james-feliciano-130000485.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>